Laura Williams - Concepedia

Author

Laura Williams

Also Known As

L Williams, L. A. Williams, L. Alexia Williams, L. Williams, L.A. Williams, LAURA A. WILLIAMS, Laura A Williams, Laura A. Williams, Laura Williams, Lilcelia A. Williams

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Abbott (United States)Northwestern University Abbott (United Kingdom)AstraZeneca (United States)

About

Laura Williams is an author at Abbott Fund specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	2.3K
2	Engineering	1	1	12
3	Nursing	1	1	12
4	Public Health	1	1	12
5	Anesthesia	1	1	61

Laura Williams

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease Adeera Levin, George L. Bakris, Mark E. Molitch, Kidney International Glomerular DiseaseNutritionUrologyRenal DiseaseRenal Function	2006	1.5K
Antiproteinuric effect of oral paricalcitol in chronic kidney disease Rajiv Agarwal, Muralidhar Acharya, Jin Tian, Kidney International UrologyRenal FunctionMedicineOral ParicalcitolPharmacotherapy	2005	372
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder Sheryl A. Kingsberg, Anita H. Clayton, David Portman, Obstetrics and Gynecology	2019	284
Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD Daniel W. Coyne, Muralidhar Acharya, Ping Qiu, American Journal of Kidney Diseases Secondary HyperparathyroidismUrologyStages 3Paricalcitol CapsuleParathyroid Hormone	2006	226
17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial Sean C. Blackwell, Cynthia Gyamfi‐Bannerman, Joseph Biggio, American Journal of Perinatology	2019	222
Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder James A. Simon, Sheryl A. Kingsberg, David Portman, Obstetrics and Gynecology	2019	196
<i>In Vitro</i> and <i>In Vivo</i> Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A Preethi Krishnan, Jill Beyer, Neeta Mistry, Antimicrobial Agents and Chemotherapy	2014	130
Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A David A. DeGoey, John T. Randolph, Dachun Liu, Journal of Medicinal Chemistry Excellent PotencyMedicinal ChemistryHcv Ns5aMedicineAntiviral Drug Development	2014	126
Effects of Fenofibric Acid on Carotid Intima-Media Thickness in Patients With Mixed Dyslipidemia on Atorvastatin Therapy Michael H. Davidson, Robert S. Rosenson, Kevin C. Maki, Arteriosclerosis Thrombosis and Vascular Biology	2014	66
Pharmacoepidemiology Safety Study of Fibrate and Statin Concomitant Therapy Cheryl Enger, Robert Gately, Eileen E. Ming, The American Journal of Cardiology Drug SafetyMedicinePharmacotherapyPharmacologyPharmacoepidemiology Safety Study	2010	65

Page 1